See more : National Beverage Corp. (FIZZ) Income Statement Analysis – Financial Results
Complete financial analysis of TMC Life Sciences Berhad (0101.KL) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of TMC Life Sciences Berhad, a leading company in the Medical – Care Facilities industry within the Healthcare sector.
- Dongyang Express Corp. (084670.KS) Income Statement Analysis – Financial Results
- HPL Electric & Power Limited (HPL.NS) Income Statement Analysis – Financial Results
- PT Wira Global Solusi Tbk (WGSH.JK) Income Statement Analysis – Financial Results
- LS 1x Apple Tracker ETC (AAPL.L) Income Statement Analysis – Financial Results
- Jiangxi Copper Company Limited (0358.HK) Income Statement Analysis – Financial Results
TMC Life Sciences Berhad (0101.KL)
About TMC Life Sciences Berhad
TMC Life Sciences Berhad, an investment holding company, provides healthcare services in Malaysia. The company operates Thomson Hospital Kota Damansara (THKD), a 559-bedded medical center located in Selangor. Its THKD provides orthopedics, ENT, head and neck laser, women and children, fertility, dietetic, and accident and emergency services. The company's fertility center offers time lapse imaging, preimplantation genetic testing, fertility genecode, and other services. It also offers fertility consultancy services; laboratory and embryology; traditional and complementary; pharmacy services and products; and management support and multi-disciplinary tertiary care services. In addition, the company operates a women's clinic and fertility centers, as well as provides related services; develops, markets, and manages healthcare programs; and operates pharmacy store. Further, it engages in the research and development activities; and property investment activities. The company was founded in 1994 and is based in Petaling Jaya, Malaysia. TMC Life Sciences Berhad is a subsidiary of Sasteria (M) Pte. Ltd.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 346.42M | 311.44M | 243.77M | 201.02M | 184.09M | 194.98M | 169.04M | 151.71M | 127.70M | 103.19M | 86.49M | 72.22M | 61.98M | 80.60M | 47.21M | 38.81M | 31.29M | 24.90M |
| Cost of Revenue | 234.54M | 90.09M | 75.79M | 66.76M | 137.98M | 57.38M | 57.07M | 52.21M | 44.11M | 36.76M | 29.90M | 26.00M | 23.04M | 28.16M | 23.97M | 18.17M | 0.00 | 0.00 |
| Gross Profit | 111.88M | 221.35M | 167.99M | 134.26M | 46.10M | 137.60M | 111.97M | 99.50M | 83.59M | 66.43M | 56.60M | 46.22M | 38.94M | 52.44M | 23.23M | 20.64M | 31.29M | 24.90M |
| Gross Profit Ratio | 32.30% | 71.07% | 68.91% | 66.79% | 25.04% | 70.57% | 66.24% | 65.59% | 65.46% | 64.38% | 65.43% | 64.00% | 62.82% | 65.06% | 49.22% | 53.18% | 100.00% | 100.00% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 85.48M | 77.72M | 0.00 | 59.68M | 49.39M | 43.05M | 42.30M | 63.56M | 26.44M | 13.74M | 0.00 | 0.00 |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 2.19M | 1.71M | 0.00 | 1.63M | 1.36M | 1.40M | 1.86M | 1.47M | 517.85K | 949.10K | 0.00 | 0.00 |
| SG&A | 0.00 | 59.26M | 43.48M | 31.41M | 30.03M | 34.02M | 87.66M | 79.43M | 71.64M | 61.31M | 50.75M | 44.45M | 44.16M | 65.03M | 26.96M | 14.69M | 0.00 | 0.00 |
| Other Expenses | 56.68M | 3.15M | 1.84M | 865.00K | 600.00K | 866.00K | 748.00K | 897.00K | 1.04M | 3.58M | 992.00K | 643.00K | 1.21M | -19.17M | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 56.68M | 178.37M | 137.91M | 109.40M | 29.43M | 107.63M | 87.72M | 80.74M | 70.49M | 57.73M | 49.76M | 43.81M | 42.95M | 84.20M | 30.19M | 16.08M | 18.30M | 12.30M |
| Cost & Expenses | 291.22M | 268.46M | 213.70M | 176.16M | 167.42M | 165.00M | 144.79M | 132.94M | 114.60M | 94.49M | 79.65M | 69.81M | 65.99M | 112.35M | 54.16M | 34.25M | 18.30M | 12.30M |
| Interest Income | 5.47M | 3.25M | 2.00M | 2.19M | 4.15M | 7.39M | 8.01M | 7.55M | 7.51M | 0.00 | 0.00 | 391.00K | -36.00K | -69.00K | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 10.25M | 9.41M | 2.10M | 441.00K | 386.40K | 85.00K | 88.00K | 85.00K | 98.00K | 101.00K | 101.00K | 312.00K | 1.95M | 3.72M | 1.85M | 512.30K | 0.00 | 0.00 |
| Depreciation & Amortization | 27.91M | 26.01M | 15.86M | 13.04M | 11.93M | 11.21M | 12.88M | 11.25M | 9.30M | 8.27M | 7.90M | 7.49M | 7.89M | 11.73M | 7.58M | 1.71M | 1.66M | 1.11M |
| EBITDA | 90.78M | 76.30M | 50.14M | 41.13M | 28.60M | 49.44M | 46.06M | 38.47M | 29.92M | 16.96M | 14.74M | 9.89M | 5.91M | -20.13M | 627.51K | 6.27M | 14.65M | 13.71M |
| EBITDA Ratio | 26.21% | 24.21% | 20.42% | 20.36% | 15.54% | 25.36% | 27.17% | 25.36% | 23.43% | 16.44% | 17.04% | 13.71% | 6.27% | -24.85% | 1.33% | 16.16% | 46.81% | 55.03% |
| Operating Income | 55.20M | 49.39M | 33.92M | 27.92M | 16.67M | 38.24M | 33.06M | 27.22M | 13.11M | 8.60M | 6.74M | 2.10M | -5.99M | -35.58M | -6.95M | 4.56M | 12.99M | 12.60M |
| Operating Income Ratio | 15.93% | 15.86% | 13.91% | 13.89% | 9.06% | 19.61% | 19.56% | 17.94% | 10.26% | 8.33% | 7.79% | 2.91% | -9.67% | -44.14% | -14.73% | 11.75% | 41.51% | 50.59% |
| Total Other Income/Expenses | -2.58M | -8.50M | -1.74M | -243.00K | 5.43M | -85.00K | 36.00K | 6.75M | -1.88M | 3.48M | 0.00 | 0.00 | 2.50M | 0.00 | -1.85M | -512.30K | 345.59K | 1.14M |
| Income Before Tax | 52.62M | 40.89M | 32.18M | 27.67M | 22.10M | 38.15M | 33.10M | 27.14M | 20.52M | 8.60M | 6.74M | 2.10M | -5.99M | -35.58M | -8.80M | 4.05M | 12.99M | 12.60M |
| Income Before Tax Ratio | 15.19% | 13.13% | 13.20% | 13.77% | 12.01% | 19.57% | 19.58% | 17.89% | 16.07% | 8.33% | 7.79% | 2.91% | -9.67% | -44.14% | -18.64% | 10.43% | 41.51% | 50.59% |
| Income Tax Expense | 11.97M | 1.63M | -9.21M | 7.42M | 6.17M | 17.23M | 5.30M | 1.11M | 5.63M | -1.33M | 283.00K | -74.00K | 426.00K | -450.00K | -52.33K | 675.33K | 3.74M | 3.43M |
| Net Income | 40.65M | 39.26M | 41.39M | 20.25M | 15.93M | 20.92M | 27.80M | 26.03M | 14.90M | 9.92M | 6.46M | 11.08M | -6.42M | -35.01M | -8.80M | 3.57M | 9.34M | 9.17M |
| Net Income Ratio | 11.73% | 12.60% | 16.98% | 10.08% | 8.65% | 10.73% | 16.44% | 17.16% | 11.66% | 9.62% | 7.47% | 15.34% | -10.36% | -43.44% | -18.65% | 9.21% | 29.85% | 36.81% |
| EPS | 0.02 | 0.02 | 0.02 | 0.01 | 0.01 | 0.01 | 0.02 | 0.02 | 0.01 | 0.01 | 0.01 | 0.01 | -0.01 | -0.06 | -0.01 | 0.01 | 0.05 | 0.05 |
| EPS Diluted | 0.02 | 0.02 | 0.02 | 0.01 | 0.01 | 0.01 | 0.02 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | -0.01 | -0.06 | -0.01 | 0.01 | 0.05 | 0.05 |
| Weighted Avg Shares Out | 1.74B | 1.74B | 1.74B | 1.74B | 1.74B | 1.74B | 1.74B | 1.73B | 1.70B | 984.97M | 802.37M | 802.37M | 690.26M | 601.78M | 655.15M | 561.91M | 188.73M | 183.26M |
| Weighted Avg Shares Out (Dil) | 1.74B | 1.74B | 1.74B | 1.74B | 1.74B | 1.74B | 1.79B | 1.89B | 2.54B | 984.97M | 1.20B | 1.20B | 867.22M | 601.78M | 655.15M | 561.91M | 188.73M | 183.26M |
Source: https://incomestatements.info
Category: Stock Reports